JAMA Network
What The Study Did: This study found that the use of buprenorphine for treatment of opioid use disorder in U.S. jails and prisons increased substantially during the past five years, although use is still rare among all incarcerated individuals with this disorder.
Authors: Ashish P. Thakrar, M.D., of the Veterans Affairs Medical Center in Philadelphia, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.38870)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
